Skip to main content
NASDAQ:ALKS

Alkermes News Headlines

$22.44
+0.10 (+0.45 %)
(As of 05/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$22.26
$22.89
50-Day Range
$18.68
$22.50
52-Week Range
$14.52
$23.92
Volume1.94 million shs
Average Volume1.39 million shs
Market Capitalization$3.60 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.25

Headlines

Alkermes (NASDAQ ALKS) News Headlines Today

SourceHeadline
Alkermes (NASDAQ:ALKS) Earns "Neutral" Rating from HC WainwrightAlkermes (NASDAQ:ALKS) Earns "Neutral" Rating from HC Wainwright
marketbeat.com - April 29 at 7:50 AM
Alkermes Plc (ALKS) Director and CEO, Alkermes plc Richard F Pops Sold $3.3 million of Shares - Yahoo FinanceAlkermes Plc (ALKS) Director and CEO, Alkermes plc Richard F Pops Sold $3.3 million of Shares - Yahoo Finance
finance.yahoo.com - May 12 at 10:18 PM
Richard F. Pops Sells 150,000 Shares of Alkermes plc (NASDAQ:ALKS) StockRichard F. Pops Sells 150,000 Shares of Alkermes plc (NASDAQ:ALKS) Stock
americanbankingnews.com - May 12 at 5:06 PM
Why Shares of Alkermes Rose 18% Last Month - NasdaqWhy Shares of Alkermes Rose 18% Last Month - Nasdaq
nasdaq.com - May 8 at 4:23 AM
Why Shares of Alkermes Rose 18% Last Month - Motley FoolWhy Shares of Alkermes Rose 18% Last Month - Motley Fool
fool.com - May 7 at 5:26 PM
Why Shares of Alkermes Rose 18% Last MonthWhy Shares of Alkermes Rose 18% Last Month
finance.yahoo.com - May 7 at 5:26 PM
Alkermes plc (NASDAQ:ALKS) CEO Sells $2,179,000.00 in StockAlkermes plc (NASDAQ:ALKS) CEO Sells $2,179,000.00 in Stock
americanbankingnews.com - May 7 at 5:24 PM
Want to Make Money in Biotech? Do This FirstWant to Make Money in Biotech? Do This First
finance.yahoo.com - May 7 at 7:24 AM
Alkermes to Take Part in the BofA Securities 2021 Virtual Healthcare Conference - Yahoo FinanceAlkermes to Take Part in the BofA Securities 2021 Virtual Healthcare Conference - Yahoo Finance
finance.yahoo.com - May 6 at 11:22 AM
Alkermes to Take Part in the BofA Securities 2021 Virtual Healthcare ConferenceAlkermes to Take Part in the BofA Securities 2021 Virtual Healthcare Conference
finance.yahoo.com - May 5 at 6:27 PM
Alkermes (NASDAQ:ALKS) Releases FY 2021 Earnings GuidanceAlkermes (NASDAQ:ALKS) Releases FY 2021 Earnings Guidance
americanbankingnews.com - May 5 at 3:46 PM
HC Wainwright Increases Alkermes (NASDAQ:ALKS) Price Target to $24.00HC Wainwright Increases Alkermes (NASDAQ:ALKS) Price Target to $24.00
americanbankingnews.com - May 5 at 10:06 AM
Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month - Yahoo FinanceAlkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month - Yahoo Finance
finance.yahoo.com - May 4 at 9:57 AM
Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness MonthAlkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month
finance.yahoo.com - May 3 at 8:49 AM
Alkermes Grants Sarissa Right To Designate Director To BoardAlkermes Grants Sarissa Right To Designate Director To Board
nasdaq.com - April 30 at 2:25 PM
Alkermes Announces Agreement with Sarissa CapitalAlkermes Announces Agreement with Sarissa Capital
finance.yahoo.com - April 30 at 9:24 AM
Alkermes PLC (ALKS) Q1 2021 Earnings Call Transcript - Motley FoolAlkermes PLC (ALKS) Q1 2021 Earnings Call Transcript - Motley Fool
fool.com - April 29 at 5:50 PM
Alkermes PLC (ALKS) Q1 2021 Earnings Call TranscriptAlkermes PLC (ALKS) Q1 2021 Earnings Call Transcript
finance.yahoo.com - April 29 at 5:50 PM
Alkermes (NASDAQ:ALKS) Price Target Increased to $24.00 by Analysts at HC WainwrightAlkermes (NASDAQ:ALKS) Price Target Increased to $24.00 by Analysts at HC Wainwright
americanbankingnews.com - April 29 at 2:16 PM
Alkermes (ALKS) Q1 Earnings Rise Y/Y, Revenues Beat Estimates - Yahoo FinanceAlkermes' (ALKS) Q1 Earnings Rise Y/Y, Revenues Beat Estimates - Yahoo Finance
finance.yahoo.com - April 29 at 12:49 PM
Alkermes (ALKS) Q1 Earnings Rise Y/Y, Revenues Beat EstimatesAlkermes' (ALKS) Q1 Earnings Rise Y/Y, Revenues Beat Estimates
finance.yahoo.com - April 29 at 12:49 PM
Alkermes shares rise on Q1 earnings beat - Seeking AlphaAlkermes shares rise on Q1 earnings beat - Seeking Alpha
seekingalpha.com - April 28 at 8:38 PM
Alkermes (NASDAQ:ALKS) Issues FY 2021 Earnings GuidanceAlkermes (NASDAQ:ALKS) Issues FY 2021 Earnings Guidance
americanbankingnews.com - April 28 at 8:28 PM
Alkermes (NASDAQ:ALKS) Releases FY21 Earnings GuidanceAlkermes (NASDAQ:ALKS) Releases FY21 Earnings Guidance
americanbankingnews.com - April 28 at 7:24 PM
Alkermes (NASDAQ:ALKS) Releases  Earnings Results, Beats Estimates By $0.13 EPSAlkermes (NASDAQ:ALKS) Releases Earnings Results, Beats Estimates By $0.13 EPS
americanbankingnews.com - April 28 at 2:25 PM
Alkermes plc 2021 Q1 - Results - Earnings Call PresentationAlkermes plc 2021 Q1 - Results - Earnings Call Presentation
seekingalpha.com - April 28 at 12:18 PM
Alkermes EPS beats by $0.12, beats on revenue - Seeking AlphaAlkermes EPS beats by $0.12, beats on revenue - Seeking Alpha
seekingalpha.com - April 28 at 10:33 AM
Alkermes launches website about alcohol dependence - Wilmington News Journal, OHAlkermes launches website about alcohol dependence - Wilmington News Journal, OH
wnewsj.com - April 28 at 10:33 AM
Alkermes (ALKS) Q1 Earnings and Revenues Beat Estimates - Yahoo FinanceAlkermes (ALKS) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
finance.yahoo.com - April 28 at 10:33 AM
Alkermes plc Reports First Quarter 2021 Financial ResultsAlkermes plc Reports First Quarter 2021 Financial Results
finance.yahoo.com - April 28 at 10:33 AM
Alkermes Announces Two Abstracts Accepted for Presentation at 2021 American Society of Clinical Oncology Annual MeetingAlkermes Announces Two Abstracts Accepted for Presentation at 2021 American Society of Clinical Oncology Annual Meeting
finance.yahoo.com - April 28 at 10:33 AM
Alkermes (ALKS) Q1 Earnings and Revenues Beat EstimatesAlkermes (ALKS) Q1 Earnings and Revenues Beat Estimates
finance.yahoo.com - April 28 at 10:33 AM
Alkermes Initiates ARTISTRY-6 Trial of Nemvaleukin Alfa Monotherapy in Patients With MelanomaAlkermes Initiates ARTISTRY-6 Trial of Nemvaleukin Alfa Monotherapy in Patients With Melanoma
finance.yahoo.com - April 27 at 8:26 AM
Alkermes gains as Mizuho expects earnings beat - Seeking AlphaAlkermes gains as Mizuho expects earnings beat - Seeking Alpha
seekingalpha.com - April 26 at 2:37 PM
Alkermes (NASDAQ:ALKS) PT Raised to $29.00 at MizuhoAlkermes (NASDAQ:ALKS) PT Raised to $29.00 at Mizuho
americanbankingnews.com - April 26 at 1:48 PM
Alkermes Plc (ALKS) SVP, CFO Iain Michael Brown Sold $700,000 of Shares - Yahoo FinanceAlkermes Plc (ALKS) SVP, CFO Iain Michael Brown Sold $700,000 of Shares - Yahoo Finance
finance.yahoo.com - April 21 at 8:49 PM
Alkermes to Host Conference Call to Discuss First Quarter 2021 Financial Results - Yahoo FinanceAlkermes to Host Conference Call to Discuss First Quarter 2021 Financial Results - Yahoo Finance
finance.yahoo.com - April 21 at 8:49 PM
Alkermes to Host Conference Call to Discuss First Quarter 2021 Financial ResultsAlkermes to Host Conference Call to Discuss First Quarter 2021 Financial Results
finance.yahoo.com - April 21 at 8:49 PM
Alkermes Plc (ALKS) EVP R&D, Chief Medical Officer Craig C. Hopkinson Sold $570,302 of Shares - Yahoo FinanceAlkermes Plc (ALKS) EVP R&D, Chief Medical Officer Craig C. Hopkinson Sold $570,302 of Shares - Yahoo Finance
finance.yahoo.com - April 16 at 10:27 PM
UK Stock News: Elliott Management Builds Significant Stake in GSK: Source - BloombergUK Stock News: Elliott Management Builds Significant Stake in GSK: Source - Bloomberg
bloomberg.com - April 15 at 10:17 AM
Alkermes partners with CMH for free employee vaccine clinic - Wilmington News Journal, OHAlkermes partners with CMH for free employee vaccine clinic - Wilmington News Journal, OH
wnewsj.com - April 14 at 6:54 PM
Is ALKS Stock A Buy or Sell? - Yahoo FinanceIs ALKS Stock A Buy or Sell? - Yahoo Finance
finance.yahoo.com - April 14 at 1:53 PM
Is ALKS Stock A Buy or Sell?Is ALKS Stock A Buy or Sell?
finance.yahoo.com - April 14 at 1:53 PM
Alkermes PLC Stock Is Believed To Be Fairly Valued - Yahoo FinanceAlkermes PLC Stock Is Believed To Be Fairly Valued - Yahoo Finance
finance.yahoo.com - April 9 at 2:08 PM
Alkermes (ALKS) Inks Deal With Merck for Ovarian Cancer Study - Yahoo FinanceAlkermes (ALKS) Inks Deal With Merck for Ovarian Cancer Study - Yahoo Finance
finance.yahoo.com - April 8 at 1:45 PM
Alkermes (ALKS) Inks Deal With Merck for Ovarian Cancer StudyAlkermes (ALKS) Inks Deal With Merck for Ovarian Cancer Study
finance.yahoo.com - April 8 at 1:45 PM
Alkermes and Merck team up for late-stage ovarian cancer study - Seeking AlphaAlkermes and Merck team up for late-stage ovarian cancer study - Seeking Alpha
seekingalpha.com - April 7 at 11:58 PM
Alkermes Announces Clinical Trial Collaboration and Supply Agreement With MSD to Evaluate Nemvaleukin Alfa in Combination With KEYTRUDA® in Patients With Platinum-Resistant Ovarian CancerAlkermes Announces Clinical Trial Collaboration and Supply Agreement With MSD to Evaluate Nemvaleukin Alfa in Combination With KEYTRUDA® in Patients With Platinum-Resistant Ovarian Cancer
finance.yahoo.com - April 7 at 8:56 AM
Achieve Life Sciences (NASDAQ:ACHV) Is In A Good Position To Deliver On Growth Plans - NasdaqAchieve Life Sciences (NASDAQ:ACHV) Is In A Good Position To Deliver On Growth Plans - Nasdaq
nasdaq.com - April 6 at 11:48 PM
When Will Alkermes plc (NASDAQ:ALKS) Turn A Profit? - NasdaqWhen Will Alkermes plc (NASDAQ:ALKS) Turn A Profit? - Nasdaq
nasdaq.com - April 6 at 6:47 PM
An Intrinsic Calculation For Alkermes plc (NASDAQ:ALKS) Suggests Its 30% Undervalued - Yahoo FinanceAn Intrinsic Calculation For Alkermes plc (NASDAQ:ALKS) Suggests It's 30% Undervalued - Yahoo Finance
finance.yahoo.com - March 31 at 9:20 AM
This page was last updated on 5/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.